New PTSD biotypes enables improved tests, sheds light on divergent treatments efficacy

Metformin use reduces risk of death for patients with COVID-19 and diabetes
14 January 2021
Northern Brazilian state declares curfew over virus
14 January 2021

New PTSD biotypes enables improved tests, sheds light on divergent treatments efficacy

Researchers from the PTSD Systems Biology Consortium, led by scientists from the Walter Reed Army Institute of Research, have identified distinct biotypes for post-traumatic stress disorder, the first of their kind for any psychological disorder. “These biotypes can refine the development of screening tools and may explain the varying efficacy of PTSD treatments,” said Dr. Marti Jett, leader of the consortium and WRAIR chief scientist.

Comments are closed.